Next Article in Journal
Construction and Characterization of Immortalized Skin Fibroblasts from Milu Deer
Previous Article in Journal
Testicular Neoplasms and Other Abnormalities in Common Carp Cyprinus carpio from the Lower Colorado River, United States
Previous Article in Special Issue
First Case Report of Choledochoenterostomy in a Cat with Biliary Obstruction Due to Cholangiohepatitis and Papillary Stenosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Case Report

A Case of Feline Eosinophilic Sclerosing Fibroplasia Associated with a Duodenal Mass Responsive to Exclusive Glucocorticoid Therapy

1
Anicura Policlinico Veterinario Roma Sud, 00173 Roma, Italy
2
Ospedale Veterinario Lido Roma, 00121 Salerno, Italy
3
Department of Veterinary Sciences, University of Messina, 98168 Messina, Italy
*
Author to whom correspondence should be addressed.
Animals 2025, 15(19), 2888; https://doi.org/10.3390/ani15192888
Submission received: 14 September 2025 / Revised: 1 October 2025 / Accepted: 2 October 2025 / Published: 2 October 2025
(This article belongs to the Special Issue Advances in Small Animal Gastrointestinal and Hepatic Diseases)

Simple Summary

Feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) is a rare inflammatory disease in cats that can mimic cancer due to the presence of firm intestinal masses. In this report, we describe a 6-year-old cat showing chronic vomiting and weight loss, in which FGESF was diagnosed after detecting a duodenal mass during endoscopy. Treatment with oral prednisolone alone led to rapid clinical improvement and complete disappearance of the mass within 30 days. A minor relapse was managed by adjusting the steroid dose. The cat has remained healthy and symptom-free for over a year. This case highlights that FGESF can respond well to medical therapy alone, avoiding the need for surgery.

Abstract

This report describes a case of feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) in a 6-year-old spayed female European Shorthair cat presenting with chronic vomiting and weight loss. Endoscopic examination revealed a submucosal duodenal mass, and histopathological evaluation of endoscopic biopsies confirmed a diagnosis of FGESF. The cat was treated exclusively with oral prednisolone (1 mg/kg SID), leading to complete clinical remission within 15 days. Follow-up ultrasonography and endoscopy performed 30 days later confirmed full resolution of the mass, which was replaced by a focal mucosal depression. Histopathology at that site revealed chronic-active lymphoplasmacytic and neutrophilic enteritis with mild fibroplasia. A mild recurrence of duodenal thickening was observed after steroid tapering, which resolved upon dosage adjustment. The patient has remained clinically stable for 15 months with normal imaging and blood parameters.
Keywords: FGESF; feline; duodenal mass; eosinophilic inflammation; glucocorticoid therapy FGESF; feline; duodenal mass; eosinophilic inflammation; glucocorticoid therapy

Share and Cite

MDPI and ACS Style

Pultrone, M.; Erba, D.; Pugliese, M. A Case of Feline Eosinophilic Sclerosing Fibroplasia Associated with a Duodenal Mass Responsive to Exclusive Glucocorticoid Therapy. Animals 2025, 15, 2888. https://doi.org/10.3390/ani15192888

AMA Style

Pultrone M, Erba D, Pugliese M. A Case of Feline Eosinophilic Sclerosing Fibroplasia Associated with a Duodenal Mass Responsive to Exclusive Glucocorticoid Therapy. Animals. 2025; 15(19):2888. https://doi.org/10.3390/ani15192888

Chicago/Turabian Style

Pultrone, Mario, Dyana Erba, and Michela Pugliese. 2025. "A Case of Feline Eosinophilic Sclerosing Fibroplasia Associated with a Duodenal Mass Responsive to Exclusive Glucocorticoid Therapy" Animals 15, no. 19: 2888. https://doi.org/10.3390/ani15192888

APA Style

Pultrone, M., Erba, D., & Pugliese, M. (2025). A Case of Feline Eosinophilic Sclerosing Fibroplasia Associated with a Duodenal Mass Responsive to Exclusive Glucocorticoid Therapy. Animals, 15(19), 2888. https://doi.org/10.3390/ani15192888

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop